,@type,@created,@updated,drugbank-id,name,cas-number,unii,average-mass,monoisotopic-mass,groups,mixtures,manufacturers,atc-codes,experimental-properties,snp-effects,snp-adverse-drug-reactions,targets,enzymes,carriers,transporters,logP,logS,Water Solubility,IUPAC Name,Traditional IUPAC Name,Molecular Weight,Monoisotopic Weight,SMILES,Molecular Formula,InChI,InChIKey,Polar Surface Area (PSA),Refractivity,Polarizability,Rotatable Bond Count,H Bond Acceptor Count,H Bond Donor Count,pKa (strongest acidic),pKa (strongest basic),Physiological Charge,Number of Rings,Bioavailability,Rule of Five,Ghose Filter,MDDR-Like Rule,atc_code,atc_code_$,atc_code_0,atc_code_0_$,atc_code_1,atc_code_1_$,atc_code_2,atc_code_2_$,atc_code_3,atc_code_3_$
0,small molecule,2022-12-02,2022-12-03,DB17297,Enitociclib,1610408-97-3,1255AT22ZJ,404.44,404.111853336,investigational,,,,,,,,,,,3.71,-4.7,7.76e-03 g/l,(S)-[(2-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methyl](imino)methyl-lambda6-sulfanone,(S)-[(2-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methyl](imino)methyl-lambda6-sulfanone,404.44,404.111853336,COC1=C(C=CC(F)=C1)C1=CC(NC2=NC=CC(C[S@@](C)(=N)=O)=C2)=NC=C1F,C19H18F2N4O2S,"InChI=1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25)/t28-/m0/s1",YZCUMZWULWOUMD-NDEPHWFRSA-N,87.96,103.02,39.71,6,6,2,13.52,4.46,0,3,1,1,1,1,,,,,,,,,,
1,small molecule,2022-12-02,2022-12-13,DB17298,Disufenton,168021-77-0,797K01YF1M,337.36,337.028994175,investigational,,,,,,,,,,,-2.1,-2.9,3.98e-01 g/l,"(Z)-tert-butyl[(2,4-disulfophenyl)methylidene]oxidoazanium","(Z)-tert-butyl[(2,4-disulfophenyl)methylidene]oxidoazanium",337.36,337.028994175,CC(C)(C)[N+](\[O-])=C\C1=C(C=C(C=C1)S(O)(=O)=O)S(O)(=O)=O,C11H15NO7S2,"InChI=1S/C11H15NO7S2/c1-11(2,3)12(13)7-8-4-5-9(20(14,15)16)6-10(8)21(17,18)19/h4-7H,1-3H3,(H,14,15,16)(H,17,18,19)/b12-7-",OVTCHWSLKGENKP-GHXNOFRVSA-N,134.81,78.1,31.55,4,7,2,-2.9,,-2,1,1,1,0,0,,,,,,,,,,
